The Stereotaxis remote magnetic navigation system has been designed to enhance patient care in international medicine. It offers an innovative and economical option for treatment of complex arrhythmias with an unparalleled safety profile for both patients and healthcare providers.
The On-X aortic heart valve is the only mechanical valve FDA approved and clinically proven to be safer with less anticoagulation. In a prospective randomized clinical trial, On-X aortic heart valve patients with a reduced warfarin dose (INR 1.5–2.0) had 65% fewer harmful bleeding events without an increase in stroke risk. On-X aortic and mitral prosthetic valves have been safely implanted in approximately 200,000 patients worldwide.